High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N92024D00013
Awardee
Awarding agency
Task orders
15 $24,448,542 obligated

Award facts

Opportunity
Combined order value
  • $24,448,542 Current, with exercised options
  • $36,231,480 Potential, with all options
Last date to order 34% complete
IDV ceiling 25% used
$98,880,900.00
Award type
Single award
Who can order
Only the awarding agency
Funding agency
National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Human Genome Research Institute awarded a single-award indefinite delivery contract to The Johns Hopkins University on June 1, 2024, with a ceiling value of $98,880,900 for high-throughput genotyping and DNA sequencing services to study the genetic contributions to human health and disease. The contract runs through May 31, 2031.

Work is performed in Baltimore, Maryland. The originating solicitation, posted September 21, 2023, sought high-throughput genotyping and DNA sequencing capabilities supporting genetic research across the National Institutes of Health.

Johns Hopkins has issued multiple delivery orders under this IDIQ. Recent task orders include a $19.81 million cost-no-fee delivery order for program management services through May 31, 2031; a $5.305 million firm fixed-price order from the National Heart Lung and Blood Institute through September 25, 2028; a $2.5565 million firm fixed-price order from the National Cancer Institute for whole exome sequencing of saliva samples and genome sequencing upgrades through September 1, 2027; a $1.2635 million firm fixed-price order from NCI for EPIC Methylation Array sequencing through September 8, 2027; and a $1.019 million firm fixed-price order from NCI for methylation array and genotyping analysis through September 8, 2027. Additional smaller orders address whole genome sequencing for targeted studies (Beebe-Dimmer, Cozen, Quinlan), Illumina Global Diversity Array work for NCI and NHGRI, whole exome sequencing efforts for NCI, and methylation assays supporting multiple NIH institutes including the National Eye Institute and National Institute of Environmental Health Sciences. Task orders span firm fixed-price and cost-no-fee pricing structures.

Task orders

Task order Ordering agency Obligated Awarded
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease… 75N98026F00002 Office of Logisitics and Acquisition Operations (NIH) $919,500
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease 75N98026F00001 Office of Logisitics and Acquisition Operations (NIH) $4,053,175
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease 75N92025F00003 National Heart Lung and Blood Institute (NIH) $5,305,029
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease: whole… 75N92025F00001 National Heart Lung and Blood Institute (NIH) $262,500
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease: whole… 75N92025F00002 National Heart Lung and Blood Institute (NIH) $317,275
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease… 75N92024F00010 National Heart Lung and Blood Institute (NIH) $13,875
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease -whole… 75N92024F00009 National Heart Lung and Blood Institute (NIH) $182,700
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease… 75N92024F00008 National Heart Lung and Blood Institute (NIH) $2,400
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease… 75N92024F00007 National Heart Lung and Blood Institute (NIH) $72,335
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease… 75N92024F00006 National Heart Lung and Blood Institute (NIH) $416,000
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease - epic… 75N92024F00005 National Heart Lung and Blood Institute (NIH) $1,018,995
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease… 75N92024F00004 National Heart Lung and Blood Institute (NIH) $1,263,500
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease -whole… 75N92024F00003 National Heart Lung and Blood Institute (NIH) $2,556,500
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease… 75N92024F00002 National Heart Lung and Blood Institute (NIH) $37,520
High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease… 75N92024F00001 National Heart Lung and Blood Institute (NIH) $8,027,238
Show all 15

Transactions

Action Obligated Date
Other Administrative Action P00002 · EO 14398, RFO, INV, non-commercial BOT, high throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease $0
Other Administrative Action P00001 $0
Original award $0

Subawards

Subcontractor Amount Awarded
Pacific Biosciences Of California, Inc. HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE Revio SPRQNx reagent kit, 24-pack SMRTbell prep… $60,660
Beckman Coulter, Inc. HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE - GLOBAL DIVERSITY ARRAY + PGX FOR NHGRI… $168,011
Illumina, Inc. HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE NovaSeq 4-lane kits and NovaSeq 6000 S4 Reagent… $33,122
Revvity Health Sciences, Inc. HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE - PROGRAM MANAGEMENT Service contract renewal $50,223
Illumina, Inc. HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE - PROGRAM MANAGEMENT NovaSeq X Plus Silver… $67,925
Illumina, Inc. HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE - PROGRAM MANAGEMENT Illumina DNA/RNA UD… $2,019,624
Illumina, Inc. HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE - PROGRAM MANAGEMENT Illumina Analytics… $49,000
Twist Bioscience Corporation HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE FlexPrep UHT Library PrepKit, 1152smp… $38,400

Quick answers

Who was awarded contract 75N92024D00013?

75N92024D00013 was awarded to The Johns Hopkins University by National Heart Lung and Blood Institute (National Institutes of Health) on June 1, 2024.

How much is contract 75N92024D00013 worth?

Orders under 75N92024D00013 have obligated $24,448,542. Their combined potential value, with all options, is $36,231,480. 75N92024D00013's own ceiling is $98,880,900.

How many orders have been placed under contract 75N92024D00013?

15 orders have been placed under 75N92024D00013, the latest on September 4, 2026.

Which agency awarded contract 75N92024D00013?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92024D00013, with funding from National Human Genome Research Institute (National Institutes of Health).

Who can order from contract 75N92024D00013?

75N92024D00013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N92024D00013 competed?

The extent of competition for 75N92024D00013 was full and open competition. The government received 6 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV